HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High rehospitalization rate in alcohol-induced psychotic disorder.

Abstract
Little is known about the prevalence and in particular the outcome of alcohol-induced psychotic disorder (AIPD). Data from hospital statistics of the BARMER GEK, one of the major health insurance companies in Germany, show a low overall prevalence of AIPD. An analysis of readmission rates for patients hospitalized for AIPD in 2005 (N = 462) and 2006 (N = 404) for the period up to 2010 revealed very high readmission rates. Only a minority of patients were without relapse [144 (31.2%) of the 2005 sample; 152 (37.6%) of the 2006 sample]. Thus, AIPD appears to be a rare complication of the alcohol use disorder but to have an extremely high rehospitalization rate, probably indicating a more chronic course and worse prognosis than previously thought. More follow-up studies are needed to elucidate this syndrome.
AuthorsMichael Soyka, Bernd Helten, Marcus Cleves, Peggy Schmidt
JournalEuropean archives of psychiatry and clinical neuroscience (Eur Arch Psychiatry Clin Neurosci) Vol. 263 Issue 4 Pg. 309-13 (Jun 2013) ISSN: 1433-8491 [Electronic] Germany
PMID23111929 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alcohol Withdrawal Delirium (psychology, therapy)
  • Alcoholism (complications, epidemiology, therapy)
  • Female
  • Germany (epidemiology)
  • Hallucinations (chemically induced, psychology)
  • Humans
  • International Classification of Diseases
  • Male
  • Middle Aged
  • Patient Readmission
  • Prevalence
  • Prognosis
  • Psychoses, Substance-Induced (epidemiology, etiology, therapy)
  • Recurrence
  • Risk Factors
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: